Clinical Research Directory
Browse clinical research sites, groups, and studies.
Summary
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress. Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
Official title: A Randomized, Placebo-Controlled Trial of Hesperidin for Fatigue,Mood, and Cognitive Function in Multiple Sclerosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-01-07
Completion Date
2027-01-18
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Interventions
Hesperidin
500 mg/day Hesperidin capsules for 12 weeks
Placebo
Matching maltodextrin capsules for 12 weeks.
Locations (1)
FHMLS, Nutrition Lab
Swansea, Wales, United Kingdom